SCHEMBL6851571

SCHEMBL6851571

CC(NC(=O)C=Cc1cc(F)cc(F)c1)c1cccc(-c2ccc(Cl)nc2)c1

nearest known ligand 0.60

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 1/20 0.45
▸ ROCK2 O75116 2/20 0.42
▸ LMNA P02545 2/20 0.41
▸ KCNQ2 O43526 2/20 0.40
▸ CYP3A4 P08684 2/20 0.40
▸ KCNQ3 O43525 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP19A1 P11511 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ LIPG Q9Y5X9 1/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ ROCK1 Q13464 1/20 0.38
▸ GSK3B P49841 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6851568 1.00 TDP1 (0.45) TDP1ROCK2LMNAKCNQ2CYP3A4
SCHEMBL6851565 1.00 TDP1 (0.45) TDP1ROCK2LMNAKCNQ2CYP3A4
SCHEMBL6626267 0.94 TDP1 (0.47) TDP1ROCK2LMNAKCNQ2CYP3A4
SCHEMBL6626270 0.94 TDP1 (0.47) TDP1ROCK2LMNAKCNQ2CYP3A4
SCHEMBL6626264 0.94 TDP1 (0.47) TDP1ROCK2LMNAKCNQ2CYP3A4
SCHEMBL30796029 0.94 TDP1 (0.47) TDP1ROCK2LMNAKCNQ2CYP3A4
SCHEMBL6629122 0.94 TDP1 (0.47) TDP1ROCK2LMNAKCNQ2CYP3A4
SCHEMBL6626118 0.92 TDP1 (0.47) TDP1ROCK2LMNAKCNQ2CYP3A4
SCHEMBL6626115 0.92 TDP1 (0.47) TDP1ROCK2LMNAKCNQ2CYP3A4
SCHEMBL6626121 0.92 TDP1 (0.47) TDP1ROCK2LMNAKCNQ2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6831080-B2 E.g., 3-(2-fluorophenyl)-N-(1-(3-morpholin-4-yl)phenyl)-propyl)acrylamide; disorders responsive to opening of KCNQ potassium channels; analgesics; migraine, bipolar disorders, anticonvulsants, antiepileptic, anxiolytic agents BRISTOL-MYERS SQUIBB COMPANY 2004-12-14 — — US disclosed
Send feedback